TECHNOLOGY: Fluorescence
A Sutent sunitinib-based fluorescent agent could help diagnose RTK-expressing cancers. The agent consists of the tyrosine kinase inhibitor (TKI) Sutent linked via a hexamethylenediamine bridge to pyrene, which fluoresces when the TKI interacts...